Startup profile · funding coverage
Dialytix funding, valuation and investors
UAB spinout Kidney Cloud platform for real-time kidney disease care management and dialysis ops.
Keep track of Dialytix
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Accelerator
$60K · April 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$60K
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
pre seed · Birmingham, AL
Investors in latest funding
Overview
Dialytix builds the Kidney Cloud platform — a federated kidney disease care management system that integrates real-time multimodal data from electronic health records, dialysis devices, and financial systems for quality improvement, operational efficiency, and capacity management. Founded in 2023 as a UAB-connected spinout (leadership includes Rubin Pillay and co-founder/CEO Ruben Raposo), the company is headquartered in Birmingham, AL. In April 2024 Dialytix was one of five health-tech startups awarded $60,000 each through the Prosper HealthTech Accelerator.
Why Dialytix is interesting
Kidney care is data-fragmented across EHRs, dialysis machines, and finance systems. Dialytix — a 2023 UAB faculty spinout — productizes that multimodal feed as Kidney Cloud, and entered Birmingham’s Prosper HealthTech accelerator with a $60K award in April 2024.
Product & use cases
Kidney Cloud aggregates device-agnostic dialysis and EHR data into dashboards and analytics for quality assurance, capacity, and financial performance in kidney disease programs.
- Dialysis and nephrology programs needing a 360° patient/ops view
- Hospitals tracking CRRT and AKI care KPIs across machines and EHRs
- Health systems reducing nurse data-entry burden between devices and finance
Key facts
- Kidney Cloud: multimodal kidney/dialysis data platform (EHR + devices + finance)
- UAB faculty spinout founded 2023; HQ Birmingham, AL
- Prosper HealthTech Accelerator (Apr 2024): $60K award among five health-tech startups
- Collaborations around AI clinical decision support for AKI/CRRT reported with UAB clinicians
Funding history (newest first)
Investors in our directory
Funds linked from Dialytix's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Kidney-specific, device-agnostic multimodal integration — narrower and deeper than general hospital analytics suites.
-
Dialysis machine vendor analytics incumbent
Often siloed to one device ecosystem.
-
General EHR/ops dashboards adjacent
Broad BI without kidney/device fusion focus.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Dialytix's financing or category context.
FAQs about Dialytix
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.